Screener
Lexicon Pharmaceuticals LXRX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
FAQ
- What is Lexicon Pharmaceuticals's operating lease liabilities (current)?
- Lexicon Pharmaceuticals (LXRX) reported operating lease liabilities (current) of $1.64M in Q2 2026.
- How has Lexicon Pharmaceuticals's operating lease liabilities (current) changed year-over-year?
- Lexicon Pharmaceuticals's operating lease liabilities (current) increased by 80.6% year-over-year, from $909K to $1.64M.
- What is the long-term trend for Lexicon Pharmaceuticals's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's operating lease liabilities (current) has grown at a 24.3% compound annual growth rate (CAGR), from $553K to $1.64M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Lexicon Pharmaceuticals's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude